• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

Member of European Parliament Nicola Caputo supports the international cooperation on in silico medicine

MEP Nicola Caputo, from the Alliance of Socialists and Democrats, agreed to sign - along with...

find out more ›

Digital Twin & CM&S to feature in Horizon Europe core text

On 17 April, the European Parliament adopted the partial agreements resulting from interinstitutional negotiations on the two Horizon Europe...

find out more ›

Launch of the MOBILISE-D Project

On 11 April, the project MOBILISE-D, a project funded by the European Innovative Medicines Initiative 2 Joint Undertaking, was launched with the aim to revolutionise...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes